← NU SKIN ENTERPRISES, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.2b | $2.3b | $2.7b | $2.4b | $2.6b | $2.7b | $2.2b | $2.0b | $1.7b | $1.5b | |
| Cost of Revenue | $500.5m | $502.1m | $634.1m | $581.4m | $658.0m | $675.2m | $630.9m | $611.9m | $550.2m | $453.8m | |
| Gross Profit | $1.7b | $1.8b | $2.0b | $1.8b | $1.9b | $2.0b | $1.6b | $1.4b | $1.2b | $1.0b | |
| Operating Expenses | $1.5b | $1.5b | $1.8b | $1.6b | $1.7b | $1.8b | $1.5b | $1.3b | $1.3b | $965.6m | |
| Operating Income (Loss) | $231.1m | $274.5m | $240.9m | $267.4m | $257.6m | $234.0m | $110.8m | $48.3m | ($151.6m) | $65.8m | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $8.4m | $8.1m | $18.3m | $13.4m | $9.8m | $11.7m | $9.7m | $11.9m | $12.3m | $7.1m | |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | — | — | — | — | — | — | — | — | $28.1m | |
| Goodwill, Impairment Loss | $0 | — | — | — | — | — | $0 | — | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($19.1m) | $1.1m | ($67.1m) | $24.2m | $71.1m | $45.4m | $24.4m | ($37.2m) | ($237.7m) | $114.2m | |
| Income (Loss) from Equity Method Investments | — | $1.0m | $456k | $0 | $0 | — | — | — | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $212.8m | $265.6m | $219.7m | $255.2m | $256.2m | $232.5m | $89.0m | $26.6m | ($175.1m) | $196.2m | |
| Net Income (Loss) Attributable to Parent | $143.1m | $129.4m | $121.9m | $173.6m | $191.4m | $147.3m | $104.8m | $8.6m | ($146.6m) | $160.2m | |
| Earnings Per Share, Basic | $2.58 | $2.45 | $2.21 | $3.13 | $3.66 | $2.93 | $2.10 | $0.17 | ($2.95) | $3.25 | |
| Earnings Per Share, Diluted | $2.55 | $2.36 | $2.16 | $3.10 | $3.63 | $2.86 | $2.07 | $0.17 | ($2.95) | $3.18 | |
| Weighted Average Number of Shares Outstanding, Basic | 55.4m | 52.8m | 55.2m | 55.5m | 52.3m | 50.2m | 50.0m | 49.7m | 49.7m | 49.3m | |
| Weighted Average Number of Shares Outstanding, Diluted | 56.1m | 54.9m | 56.5m | 55.9m | 52.8m | 51.4m | 50.5m | 49.9m | 49.7m | 50.3m | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $26.4m | $13.9m | |
| Current Income Tax Expense (Benefit) | $69.9m | $92.1m | $117.0m | $81.9m | $78.7m | $78.9m | $35.6m | $33.1m | $27.0m | $36.0m | |
| General and Administrative Expense | $554.2m | $564.5m | $662.3m | $616.0m | $646.8m | $666.4m | $555.8m | $546.9m | $479.0m | $432.1m | |
| Interest Expense | $15.6m | $22.2m | $21.8m | $19.2m | $13.1m | $11.0m | $13.5m | $25.6m | — | — | |
| Nonoperating Income (Expense) | ($18.3m) | ($8.9m) | ($21.2m) | ($12.3m) | ($1.3m) | ($1.5m) | ($21.9m) | ($21.7m) | $2.9m | ($31.8m) | |
| Research and Development Expense | $24.3m | $22.0m | $23.0m | $30.1m | $23.3m | $27.2m | $23.3m | $22.6m | $13.0m | $10.8m | |
| Restructuring Costs | — | — | $15.5m | — | — | — | — | — | — | — | |
| Selling Expense | $922.1m | $938.0m | $1.1b | $955.6m | $1.0b | $1.1b | $879.6m | $742.4m | $652.0m | $508.4m | |
| Income Tax Expense (Benefit) | $69.8m | $136.1m | $97.8m | $81.6m | $64.9m | $85.2m | ($15.8m) | $18.0m | ($28.5m) | $36.0m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.